Development of solid lipid nanoparticles based controlled release system for topical delivery of terbinafine hydrochloride

European Journal of Pharmaceutical Sciences

Volumn 49, Issue 2, 2013, Pages 311-322

  Vaghasiya, Harshad ^a   Kumar, Abhinesh ^a   Sawant, Krutika ^a  

^a M S UNIVERSITY OF BARODA   (India)

Author keywords

Carbopol gel; Factorial design; Skin targeting; Solid lipid nanoparticles; Terbinafine hydrochloride; Topical delivery

Indexed keywords

CARBOMER; GLYCEROL BEHENATE; ORGANIC SOLVENT; SOLID LIPID NANOPARTICLE; SURFACTANT; TERBINAFINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANDIDA ALBICANS; CONTROLLED RELEASE FORMULATION; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DISPERSION; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG PENETRATION; DRUG RELEASE; DRUG RETENTION; DRUG STABILITY; FACTORIAL DESIGN; FEMALE; NONHUMAN; PARTICLE SIZE; PH; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; RAT; SKIN CANDIDIASIS; TRANSMISSION ELECTRON MICROSCOPY; ZETA POTENTIAL;

ADMINISTRATION, TOPICAL; ANIMALS; ANTIFUNGAL AGENTS; CANDIDA ALBICANS; CANDIDIASIS; DELAYED-ACTION PREPARATIONS; DIGLYCERIDES; DRUG STABILITY; FATTY ACIDS; FEMALE; MALE; NANOPARTICLES; NAPHTHALENES; RATS; SKIN;

EID: 84877072304     PISSN: 09280987     EISSN: 18790720     Source Type: Journal    
DOI: 10.1016/j.ejps.2013.03.013     Document Type: Article

References (49)

1. K. Adinarayana, and P. Ellaiah Response surface optimization of the critical medium components for the production of alkaline protease by a newly isolated Bacillus sp. J. Pharm. Pharm. Sci. 5 2002 272 278
2. R. Alvarez-Roman, A. Naik, Y.N. Kalia, R.H. Guy, and H. Fessi Enhancement of topical delivery from biodegradable nanoparticles Pharm. Res. 21 2004 1818 1825
3. T. Arika, M. Yokoo, T. Hase, T. Maeda, K. Amemiya, and H. Yamaguchi Effects of butenafine hydrochloride, a new benzylamine derivative, on experimental dermatophytosis in guinea pigs Antimicrob. Agents Chemother. 34 1990 2250 2253
4. A.A. Attama SLN, NLC, LDC: state of the art in drug and active delivery Recent Pat. Drug Deliv. Formul. 5 2011 178 187
5. A.A. Attama, S. Reichl, and C.C. Müller-Goymann Diclofenac sodium delivery to the eye: in vitro evaluation of novel solid lipid nanoparticle formulation using human cornea construct Int. J. Pharm. 355 2008 307 313
6. P. Beck, D. Scherer, and J. Kreuter Separation of drug-loaded nanoparticles from free drug by gel filtration J. Microencapsul. 7 1990 491 496
7. M.R. Bhalekar, V. Pokharkar, A. Madgulkar, and N. Patil Preparation and evaluation of miconazole nitrate-loaded solid lipid nanoparticles for topical delivery AAPS PharmSciTech 10 2009 289 296
8. S. Bolton, and C. Bon Pharmaceutical Statistics: Practical and Clinical Applications third ed. 1997 Marcel Dekker Inc. New York
9. G. Cevc Lipid vesicles and other colloids as drug carriers on the skin Adv. Drug Deliv. Rev. 56 2004 675 711
10. T. de Vringer, and H.A. de Ronde Preparation and structure of a water-in-oil cream containing lipid nanoparticles J. Pharm. Sci. 84 1995 466 472
11. G.C. Derringer, and R. Suich Simultaneous optimization of several response variables J. Qual. Technol. 12 1980 214 219
12. Y.S. El-Saharty, N.Y. Hassan, and F.H. Metwally Simultaneous determination of terbinafine HCL and triamcinolone acetonide by UV derivative spectrophotometry and spectrodensitometry J. Pharm. Biomed. Anal. 28 2002 569 580
13. S. Feng, and G. Huang Effects of emulsifiers on the controlled release of paclitaxel (Taxol) from nanospheres of biodegradable polymers J. Control. Release 71 2001 53 69
14. T.J. Franz Percutaneous absorption on the relevance of in vitro data J. Invest. Dermatol. 64 1975 190 195
15. C. Freitas, and R.H. Müller Effect of light and temperature on zeta potential and physical stability in solid lipid nanoparticle (SLN™) dispersions Int. J. Pharm. 168 1998 221 229
16. C. Freitas, and R.H. Muller Stability determination of solid lipid nanoparticles (SLN) in aqueous dispersion after addition of electrolyte J. Microencapsul. 16 1999 59 71
17. C. Freitas, and R.H. Müller Correlation between long-term stability of solid lipid nanoparticles (SLN™) and crystallinity of the lipid phase Eur. J. Pharm. Biopharm. 47 1999 125 132
18. R.J. Hunter Foundations of Colloid Science 1987 Calderon Press Oxford
19. V. Jenning, M. Schäfer-Korting, and S. Gohla Vitamin A-loaded solid lipid nanoparticles for topical use: drug release properties J. Control. Release 66 2000 115 126
20. S. Kumar, and J.K. Randhawa Preparation and characterization of Paliperidone loaded solid lipid nanoparticles Colloid. Surf. B: Biointerf. 102 2013 562 568
21. J. Liu, W. Hu, H. Chen, Q. Ni, H. Xu, and X. Yang Isotretinoin-loaded solid lipid nanoparticles with skin targeting for topical delivery Int. J. Pharm. 328 2007 191 195
22. W. Liu, M. Hu, C. Xue, H. Xu, and X. Yang Investigation of the carbopol gel of solid lipid nanoparticles for the transdermal iontophoretic delivery of triamcinolone acetonide acetate Int. J. Pharm. 364 2008 135 141
23. Q. Lv, A. Yu, Y. Xi, H. Li, Z. Song, J. Cui, F. Cao, and G. Zhai Development and evaluation of penciclovir-loaded solid lipid nanoparticles for topical delivery Int. J. Pharm. 372 2009 191 198
24. S.D. Mandawgade, and V.B. Patravale Development of SLNs from natural lipids: application to topical delivery of tretinoin Int. J. Pharm. 363 2008 132 138
25. W. Mehnert, and K. Mader Solid lipid nanoparticles: production, characterization and applications Adv. Drug Deliv. Rev. 47 2001 165 196
26. A.K. Mehta, K.S. Yadav, and K.K. Sawant Nimodipine loaded PLGA nanoparticles: formulation optimization using factorial design, characterization and in vitro evaluation Curr. Drug Deliv. 4 2007 185 193
27. Z. Mei, H. Chen, T. Weng, Y. Yang, and X. Yang Solid lipid nanoparticle and microemulsion for topical delivery of triptolide Eur. J. Pharm. Biopharm. 56 2003 189 196
28. L. Montenegro, C. Sinico, I. Castangia, C. Carbone, and G. Puglisi Idebenone-loaded solid lipid nanoparticles for drug delivery to the skin: in vitro evaluation Int. J. Pharm. 434 2012 169 174
29. R.H. Muller, K. Mader, and S. Gohla Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art Eur. J. Pharm. Biopharm. 50 2000 161 177
30. R.H. Muller, M. Radtke, and S.A. Wissing Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations Adv. Drug Deliv. Rev. 54 Suppl. 1 2002 S131 S155
31. R.H. Muller, W. Mehnert, and E.B. Souto Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) for dermal delivery L. Bronaugh, Percutaneous Absorption 2005 Marcel Dekker, Inc. New York, Basel, Hong-Kong 719 738
32. K. Padois, C. Cantieni, V. Bertholle, C. Bardel, F. Pirot, and F. Falson Solid lipid nanoparticles suspension versus commercial solutions for dermal delivery of minoxidil Int. J. Pharm. 416 2011 300 304
33. K. Raza, B. Singh, P. Singal, S. Wadhwa, and O.P. Katare Systematically optimized biocompatible isotretinoin-loaded solid lipid nanoparticles (SLNs) for topical treatment of acne Colloid. Surf. B: Biointerf. 2013
34. M.A. Schubert, and C.C. Muller-Goymann Solvent injection as a new approach for manufacturing lipid nanoparticles - evaluation of the method and process parameters Eur. J. Pharm. Biopharm. 55 2003 125 131
35. S.C. Shin, J.Y. Kim, and I.J. Oh Mucoadhesive and physicochemical characterization of Carbopol-Poloxamer gels containing triamcinolone acetonide Drug Dev. Ind. Pharm. 26 2000 307 312
36. B. Siekmann, and K. Westesen Thermoanalysis of the recrystallization process of melt-homogenized glyceride nanoparticles Colloid. Surf. B: Biointerf. 3 1994 159 175
37. A. Silva, D. Santos, D. Ferreira, and E. Souto Characterization of ibuprofen loaded solid lipid nanoparticles dispersed in semi-solid Carbopol gels J. Biotechnol. 131 2007 S67 S68
38. E.B. Souto, S.A. Wissing, C.M. Barbosa, and R.H. Muller Development of a controlled release formulation based on SLN and NLC for topical clotrimazole delivery Int. J. Pharm. 278 2004 71 77
39. N. Subramanian, A. Yajnik, and R.S. Murthy Artificial neural network as an alternative to multiple regression analysis in optimizing formulation parameters of cytarabine liposomes AAPS PharmSciTech 5 2004 E4
40. Y. Tatsumi, M. Yokoo, T. Arika, and H. Yamaguchi In vitro antifungal activity of KP-103, a novel triazole derivative, and its therapeutic efficacy against experimental plantar tinea pedis and cutaneous candidiasis in guinea pigs Antimicrob. Agents Chemother. 45 2001 1493 1499
41. M. Trotta, E. Peira, M.E. Carlotti, and M. Gallarate Deformable liposomes for dermal administration of methotrexate Int. J. Pharm. 270 2004 119 125
42. K. Uchida, T. Tanaka, and H. Yamaguchi Achievement of complete mycological cure by topical antifungal agent NND-502 in guinea pig model of tinea pedis Microbiol. Immunol. 47 2003 143 146
43. T. Unruh, H. Bunjes, K. Westesen, and M.H.J. Koch Observation of size-dependent melting in lipid nanoparticles J. Phys. Chem. B 103 1999 10373 10377
44. V. Venkateswarlu, and K. Manjunath Preparation, characterization and in vitro release kinetics of clozapine solid lipid nanoparticles J. Control. Release 95 2004 627 638
45. A.C. Williams, and B.W. Barry Penetration enhancers Adv. Drug Deliv. Rev. 56 2004 603 618
46. S. Wissing, and R. Müller Solid lipid nanoparticles (SLN) - a novel carrier for UV blockers Pharmazei 56 2001 783 786
47. S.A. Wissing, and R.H. Muller The influence of solid lipid nanoparticles on skin hydration and viscoelasticity - in vivo study Eur. J. Pharm. Biopharm. 56 2003 67 72
48. A. zur Muhlen, and W. Mehnert Drug release and release mechanism of prednisolone loaded solid lipid nanoparticles Pharmazie 53 1998 552 555
49. A. zur Muhlen, E. zur Muhlen, H. Niehus, and W. Mehnert Atomic force microscopy studies of solid lipid nanoparticles Pharm. Res. 13 1996 1411 1416